The goal of this single arm pre-post study is to assess the feasibility, acceptability, and preliminary impact of the LOTUS intervention to improve HIV prevention service engagement among people who use drugs. LOTUS is a technology-delivered intervention that provides HIV prevention informational content and tips, peer social support and social networking features, a resource locator, HIV prevention monitoring and reminders (e.g., reminders for HIV/STI testing and PrEP doses), and a virtual space to have questions answered by health care professionals.
18 years of age or older
Report weekly or daily use of opioids and/or stimulants in the past 6 months
Meet current CDC eligibility criteria for PrEP
Report low levels of HIV prevention service engagement in the past 6 months
17 years of age or younger
Does not report weekly or daily use of opioids and/or stimulants in the past 6 months
Does not meet current CDC eligibility criteria for PrEP
Report high levels of HIV prevention service engagement in the past 6 months
Single group
LOTUS mHealth Intervention Group
BehavioralA mobile, WebApp-based intervention comprised of tips for HIV prevention, a community wall for peer interaction and support, HIV prevention monitoring and reminders, a virtual space to have questions answered by a healthcare professional, a resource database, and a personalized profile. Intervention components are designed to promote HIV prevention service use and improve social support, coping strategies, and positive affect.
LOTUS Feasibility
The feasibility of the LOTUS mHealth intervention will be measured by participant retention and via intervention use data.
LOTUS Acceptability
The acceptability of the LOTUS mHealth intervention will be measured via the System Usability Scale (SUS), with possible scores ranging from 10-50 and higher scores indicating higher acceptability.
HIV Prevention Service Engagement
The percentage of participants who report obtaining an HIV/STI test and/or initiating PrEP
Attitudes and Perceptions
Attitudes and perceptions will be measured via the validated InDI measure, which is comprised of three subscales: anticipated, day-to-day, and major. Anticipated scores range from 0-4, day-to-day scores range from 0-18, and major scores range from 0-13.
Click on the lead sponsor to view all of their trials.
University of California, San Diego
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
